Company page

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. (Ticker: ABOS) is a public company operating in the American market, with a market capitalization of approximately $187.8 million. The company focuses on developing innovative therapies for Alzheimer's disease and related conditions. Acumen is committed to advancing its research and clinical programs to address significant unmet medical needs in this area.